Skip to main content

Table 3 Maintenance outcomes

From: A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for Opioid prescribing in primary care

Through 12 months (Maintenance) Estimated value—control clinics (6-month mark) Slope of control clinics (95% CI) p value (pre-post within control clinics) Estimated value—intervention clinics (6-month mark) Slope of intervention clinics (95% CI) p value (pre-post within intervention clinics) Slope of intervention minus control (95% CI) p value (difference between intervention—control groups)
Proportion of patients with consistent opioid Rx a 0.013 − 0.0001 (0.0000, − 0.0002) 0.007 0.012 − 0.0001 (− 0.0001, − 0.0002) 0.001 0.0000 (0.0001, − 0.0001) 0.975
Proportion with mental health screen b 0.394 0.016 (0.026, 0.006) 0.002 0.574 0.033 (0.053, 0.014) 0.001 0.017 (0.028, 0.006) 0.003
Proportion with urine drug testing b 0.440 0.012 (0.020, 0.005) 0.001 0.645 0.018 (0.029, 0.006) 0.002 0.005 (0.013, − 0.002) 0.153
Proportion with treatment agreement b 0.542 0.031 (0.048, 0.014) 0.000 0.782 0.036 (0.056, 0.015) 0.001 0.005 (0.012, − 0.002) 0.146
Average morphine-equivalent daily dose (MEDD) b, c 60.239 0.431 (0.909, − 0.048) 0.078 84.278 − 0.830 (− 0.264, − 1.396) 0.004 − 1.261 (− 0.425, − 2.097) 0.003
Proportion with MEDD > 120 b, c 0.125 − 0.000 (0.002, − 0.002) 0.942 0.191 − 0.003 (− 0.001, − 0.005) 0.004 −0.003 (− 0.001, − 0.006) 0.018
Proportion with co-prescribed benzodiazepines b 0.061 0.001 (0.002, − 0.001) 0.291 0.074 0.002 (0.004, − 0.001) 0.136 0.001 (0.003, − 0.001) 0.353
  1. aThree or more opioid prescriptions in each of the most recent 3 months
  2. bSubset of proportion a above (patients with three or more opioid prescriptions in each of the most recent 3 months)
  3. cMEDD morphine-equivalent daily dose (for patients with consistent opioid Rx)